Nova Valuation
Is NMR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NMR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NMR (€165) is trading above our estimate of fair value (€141.55)
Significantly Below Fair Value: NMR is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NMR?
Key metric: As NMR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is NMR's PE Ratio? | |
|---|---|
| PE Ratio | 30.5x |
| Earnings | US$171.35m |
| Market Cap | US$5.06b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.4x |
| Enterprise Value/EBITDA | 24.6x |
| PEG Ratio | 2x |
Price to Earnings Ratio vs Peers
How does NMR's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.9x | ||
AIXA AIXTRON | 12.8x | 6.2% | €1.4b |
WAF Siltronic | 14.8x | -17.0% | €1.4b |
SMHN SÜSS MicroTec | 21.5x | -3.4% | €940.5m |
S92 SMA Solar Technology | 2.5x | -0.9% | €396.3m |
NMR Nova | 30.5x | 15.2% | €5.1b |
Price-To-Earnings vs Peers: NMR is expensive based on its Price-To-Earnings Ratio (30.5x) compared to the peer average (12.9x).
Price to Earnings Ratio vs Industry
How does NMR's PE Ratio compare vs other companies in the European Semiconductor Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: NMR is expensive based on its Price-To-Earnings Ratio (30.5x) compared to the European Semiconductor industry average (13.7x).
Price to Earnings Ratio vs Fair Ratio
What is NMR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 30.5x |
| Fair PE Ratio | 19.9x |
Price-To-Earnings vs Fair Ratio: NMR is expensive based on its Price-To-Earnings Ratio (30.5x) compared to the estimated Fair Price-To-Earnings Ratio (19.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €165.00 | €226.91 +37.5% | 3.7% | €233.25 | €210.86 | n/a | 5 |
| Nov ’25 | €169.00 | €221.46 +31.0% | 4.1% | €230.88 | €206.86 | n/a | 5 |
| Oct ’25 | €185.00 | €218.18 +17.9% | 4.2% | €224.65 | €201.29 | n/a | 5 |
| Sep ’25 | €197.00 | €235.02 +19.3% | 5.0% | €250.04 | €219.82 | n/a | 5 |
| Aug ’25 | €189.00 | €222.63 +17.8% | 10.4% | €250.53 | €197.31 | n/a | 5 |
| Jul ’25 | €218.00 | €208.82 -4.2% | 5.5% | €224.79 | €197.26 | n/a | 5 |
| Jun ’25 | €195.00 | €206.62 +6.0% | 4.1% | €222.77 | €199.56 | n/a | 5 |
| May ’25 | €162.00 | €183.91 +13.5% | 4.5% | €197.30 | €175.69 | n/a | 4 |
| Apr ’25 | €165.70 | €179.36 +8.2% | 2.6% | €185.62 | €173.55 | n/a | 4 |
| Mar ’25 | €167.20 | €179.36 +7.3% | 2.6% | €185.62 | €173.55 | n/a | 4 |
| Feb ’25 | €134.20 | €135.54 +1.0% | 5.6% | €147.02 | €128.65 | n/a | 4 |
| Jan ’25 | €123.70 | €133.27 +7.7% | 5.6% | €144.56 | €126.49 | n/a | 4 |
| Dec ’24 | €117.50 | €126.46 +7.6% | 6.4% | €136.71 | €113.93 | n/a | 4 |
| Nov ’24 | €89.75 | €125.46 +39.8% | 1.8% | €127.74 | €123.17 | €169.00 | 4 |
| Oct ’24 | €104.50 | €125.46 +20.1% | 1.8% | €127.74 | €123.17 | €185.00 | 4 |
| Sep ’24 | €118.90 | €125.46 +5.5% | 1.8% | €127.74 | €123.17 | €197.00 | 4 |
| Aug ’24 | €112.60 | €109.32 -2.9% | 8.3% | €117.56 | €94.40 | €189.00 | 4 |
| Jul ’24 | €105.30 | €109.45 +3.9% | 7.6% | €120.07 | €97.90 | €218.00 | 4 |
| Jun ’24 | €101.20 | €108.55 +7.3% | 7.5% | €120.82 | €98.52 | €195.00 | 5 |
| May ’24 | €82.75 | €102.36 +23.7% | 5.6% | €112.21 | €96.70 | €162.00 | 5 |
| Apr ’24 | €94.60 | €104.46 +10.4% | 6.1% | €115.24 | €99.31 | €165.70 | 4 |
| Mar ’24 | €85.45 | €104.46 +22.3% | 6.1% | €115.24 | €99.31 | €167.20 | 4 |
| Feb ’24 | €83.25 | €101.37 +21.8% | 11.4% | €118.74 | €86.89 | €134.20 | 4 |
| Jan ’24 | €76.40 | €101.37 +32.7% | 11.4% | €118.74 | €86.89 | €123.70 | 4 |
| Dec ’23 | €81.75 | €101.37 +24.0% | 11.4% | €118.74 | €86.89 | €117.50 | 4 |
| Nov ’23 | €74.65 | €117.19 +57.0% | 18.4% | €142.04 | €86.24 | €89.75 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
PVA TePla
€238.6m
Develops and produces process in areas of semiconductor, metal, electrical/electronics, and optical sectors worldwide.
TPE
€10.77
7D
-9.3%
1Y
-41.6%
Renesas Electronics
JP¥3.6t
Researches, develops, designs, manufactures, sells, and services semiconductors in Japan, China, rest of Asia, Europe, North America, and internationally.
NEN0
JP¥6.05
7D
-1.6%
1Y
n/a
ON Semiconductor
US$29.2b
Provides intelligent sensing and power solutions in the United States and internationally.
XS4
US$65.08
7D
6.1%
1Y
3.2%